NMC
RARX
NEA Management Company’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,138,797
| Closed | -$295M | – | 50 |
|
|
2020
Q1 | $295M | Hold |
6,138,797
| – | – | 15.4% | 1 |
|
|
2019
Q4 | $288M | Hold |
6,138,797
| – | – | 13.62% | 1 |
|
|
2019
Q3 | $145M | Hold |
6,138,797
| – | – | 12.02% | 2 |
|
|
2019
Q2 | $185M | Hold |
6,138,797
| – | – | 12.93% | 1 |
|
|
2019
Q1 | $138M | Hold |
6,138,797
| – | – | 7.14% | 2 |
|
|
2018
Q4 | $112M | Buy |
6,138,797
+645,161
| +12% | +$11.7M | 4.43% | 5 |
|
|
2018
Q3 | $99.4M | Hold |
5,493,636
| – | – | 4.29% | 7 |
|
|
2018
Q2 | $54.7M | Hold |
5,493,636
| – | – | 2.56% | 11 |
|
|
2018
Q1 | $29.2M | Buy |
5,493,636
+2,000,000
| +57% | +$10.6M | 1.3% | 18 |
|
|
2017
Q4 | $29.7M | Hold |
3,493,636
| – | – | 1.23% | 20 |
|
|
2017
Q3 | $51M | Hold |
3,493,636
| – | – | 1.79% | 14 |
|
|
2017
Q2 | $65.5M | Hold |
3,493,636
| – | – | 2.38% | 8 |
|
|
2017
Q1 | $74.4M | Hold |
3,493,636
| – | – | 2.59% | 6 |
|
|
2016
Q4 | $53.1M | Buy |
+3,493,636
| New | +$53.1M | 2.11% | 9 |
|